Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Stock
Equities
688621
CNE100005139
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
49.13 CNY | +0.45% | -5.10% | -29.56% |
Sales 2024 * | 1.26B 174M | Sales 2025 * | 1.65B 228M | Capitalization | 5.5B 759M |
---|---|---|---|---|---|
Net income 2024 * | 277M 38.21M | Net income 2025 * | 388M 53.53M | EV / Sales 2024 * | 4.37 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.33 x |
P/E ratio 2024 * |
19.8
x | P/E ratio 2025 * |
12.4
x | Employees | 1,370 |
Yield 2024 * |
1.4% | Yield 2025 * |
1.85% | Free-Float | 52.15% |
1 day | +0.45% | ||
1 week | -5.10% | ||
Current month | -12.81% | ||
1 month | -13.55% | ||
3 months | -17.43% | ||
6 months | -26.94% | ||
Current year | -29.56% |
Managers | Title | Age | Since |
---|---|---|---|
Yu Jing Liu
CEO | Chief Executive Officer | 42 | 09-02-28 |
Ling Yang Zhao
DFI | Director of Finance/CFO | 36 | 20-03-20 |
Ming Juan Wang
CTO | Chief Tech/Sci/R&D Officer | 48 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Qian Li
CHM | Chairman | 43 | 09-03-08 |
Qiao Chen
BRD | Director/Board Member | 44 | 20-03-20 |
Zhuang Kun He
BRD | Director/Board Member | 52 | 20-03-20 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 49.13 | +0.45% | 763,223 |
24-05-27 | 48.91 | -3.38% | 2,210,151 |
24-05-24 | 50.62 | -0.16% | 890,320 |
24-05-23 | 50.7 | -2.71% | 1,213,063 |
24-05-22 | 52.11 | +0.66% | 793,483 |
End-of-day quote Shanghai S.E., May 27, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.56% | 759M | |
+54.05% | 58.71B | |
-2.02% | 41.31B | |
+37.12% | 39.2B | |
-10.22% | 27.4B | |
+13.42% | 26.55B | |
-21.60% | 18.98B | |
+2.89% | 12.51B | |
+22.40% | 11.94B | |
+27.49% | 12.08B |
- Stock Market
- Equities
- 688621 Stock